Navigation Links
AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013
Date:6/21/2013

REDWOOD CITY, Calif., June 21, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, will host an Investor Day on Thursday, June 27, 2013, from 9:00 a.m. to 11:00 a.m. EDT (6:00 a.m. to 8:00 a.m. PDT) at the 21 Club, 21 West 53rd Street, New York, NY.

Members of the AcelRx management team will present insights on the Company's Sufentanil NanoTab PCA System Phase 3 clinical trial results and discuss plans related to hospital formulary adoption and commercialization. In addition, thought leaders who treat post-operative pain in the hospital setting will discuss their experience with and perspectives on the Sufentanil NanoTab PCA System. Breakfast will be served for meeting attendees from 8:00 a.m. to 9:00 a.m. and a link to the live webcast will be available on the Investors page of the Company's website at www.acelrx.com beginning at 9:00 a.m. EDT. An archive of the webcast will be available shortly after the event through the Investors page at www.acelrx.com.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.  AcelRx's lead product candidate, the Sufentanil NanoTab PCA System, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps. The NanoTab System has
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
2. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
3. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
4. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
5. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
6. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
7. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
8. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
9. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. AcelRx Pharmaceuticals Provides Clinical Trial Updates
11. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... PALO ALTO, Calif. , July 28, 2015 /PRNewswire/ ... International Holding Corp., the parent company of CPI International, ... the third quarter ended July 3, 2015 with the ... release regarding its results for the quarter.  At 11 ... hold a telephonic conference call in conjunction with this ...
(Date:7/28/2015)... 28, 2015 /PRNewswire-USNewswire/ -- Kentucky,s ... doctor shopping after a 2012 law required providers to ... medications is yet more evidence that Californians need the ... Since Kentucky,s prescription drug abuse ... declined by 52 percent; opioid prescriptions to doctor-shopping individuals ...
(Date:7/28/2015)... DUBLIN , July 28, 2015 Research ... of the "Refurbished Medical Equipment Market - Global ... The global refurbished medical equipment market is estimated ... at a CAGR of 12.5% from 2014 to 2019. ... for low-cost medical devices due to financial constraints, increasing ...
Breaking Medicine Technology:CPI International To Announce Third Quarter 2015 Financial Results 2Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
(Date:7/28/2015)... ... 28, 2015 , ... According to WFTV on July 15th heroin ... heroin toxicity cases. According to recent statistic Orlando suffers at least one death weekly ... hub of heroin, and law enforcement officials are struggling to keep apace with its ...
(Date:7/28/2015)... ... 28, 2015 , ... Today, enterprise request management (ERM) and ... upgrade and expansion of its ERM system using Kinetic Data software. ... 134 countries supplying a wide range of business and residential energy products and ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... targeted biologics and biologic-device combination products for the treatment of bone disorders and ... U.S. Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new Taiwanese ... than they are in the general population. Surviving Mesothelioma has just posted an ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated ...
(Date:7/28/2015)... ... , ... Women fear developing Alzheimer's disease more than having a heart attack ... are treatable, but there is little an individual can do to arrest the progress ... clinical trial, reports the July 2015 Harvard Women's Health Watch . , "There ...
Breaking Medicine News(10 mins):Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3
... Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) announced today ... granted final approval for the Company,s,Abbreviated New Drug ... 300 mg (Allopurinol). Allopurinol is indicated in ... primary or secondary gout, the management of patients ...
... Aug. 31 Cleveland-based The ScottCare,Corporation, a ... cardiopulmonary rehabilitation telemetry, announced today that,the company ... the,operations of Rozinn Electronics, Inc., a privately-held ... Glendale, NY. "We are very pleased ...
... restrictive commitment,standard, ARLINGTON, Va., Aug. 31 ... needed treatment and at what point could,the Virginia ... with answering those questions released its report today, ... commitment is one of,the most restrictive in the ...
... Inc. (Nasdaq: HEII ),( http://www.heii.com ) announced ... sell substantially all of the assets of its ... subsidiary of Dutch based Smartrac N.V.,The transaction is ... assets of,the RFID division, including inventory, receivables, customer ...
... Recipes at the 34th ... Meeting, ST. LOUIS, Aug. 31 Celebrity chef ... will be,conducting a cooking demonstration at the 34th Annual ... Mo. this afternoon for,patients with chronic kidney disease (CKD). ...
... the Netherlands have identified a chemical agent that may ... syndrome (BOS), or popcorn workers lung, a severe occupational ... an American plant that makes microwaveable popcorn. ... at a chemical plant that produced diacetyl (a key ...
Cached Medicine News:Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R) 2Health News:The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products 2Health News:Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law 2Health News:HEI, Inc. Announces Sale of RFID Division Assets 2Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 2Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 3Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 4Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 5Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 6Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 7Health News:Chemical culprit in 'popcorn worker's lung' identified 2
... The Gemini Family of infusion ... with a collective series of ... product line offers a wide ... IV sets, each featuring the ...
... any hospital or health system can take ... effective tools available for physicians and nurses. ... and electronic medical record (EMR) system, helps ... In fact, its the most reliable clinical ...
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
... Care, the world-class clinician documentation and electronic ... focus on the specific needs of intensive ... Its broad, deep clinical functionality has secured ... EMR solution in critical care, and its ...
Medicine Products: